Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
Akero Therapeutics, Inc. | Director | Common Stock | 1.2M | $52.3M | $43.55 | Mar 27, 2025 | Indirect |
Olema Pharmaceuticals, Inc. | Director | Common Stock | 1.41M | $9.51M | $6.75 | Dec 17, 2024 | Indirect |
Akero Therapeutics, Inc. | Director | Common Stock | 2.17K | $94.4K | $43.55 | Mar 25, 2025 | Direct |
Akero Therapeutics, Inc. | Director | Stock Option (Right to Buy) | 26K | Jun 8, 2024 | Direct | ||
Olema Pharmaceuticals, Inc. | Director | Stock Option (right to buy) | 23K | Jun 14, 2024 | Direct | ||
ALX ONCOLOGY HOLDINGS INC | Director | Stock option (right to buy) | 12K | Jun 11, 2021 | Direct |